14.93
Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten
Artelo Biosciences Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com
Is Artelo Biosciences Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional
What drives Artelo Biosciences Inc. stock priceFree Expert Stock Watchlist - jammulinksnews.com
What analysts say about Artelo Biosciences Inc. stockConsistently superior profits - jammulinksnews.com
What makes Artelo Biosciences Inc. stock price move sharplyStable Stocks With High Yield - Newser
Artelo Biosciences Announces $6.5 Million At-The-Market Offering Agreement - AInvest
Artelo Biosciences' ATM Offering: A Delicate Balance Between Liquidity and Dilution - AInvest
Artelo Biosciences Announces At-The-Market Offering Agreement - TipRanks
What analysts say about Artelo Biosciences Inc. stock outlookMinimized Risk Maximum Return - Newser
Artelo Biosciences: KDJ Golden Cross, Bullish Marubozu on 15-Minute Chart - AInvest
Why Artelo Biosciences Inc. stock attracts strong analyst attentionFree Join Group - Newser
How Artelo Biosciences Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
Artelo Biosciences Plummets Over 22%—What's Driving the Freefall? - AInvest
Artelo Biosciences Stock Soars 114% After Promising Depression Treatment Data - MSN
Artelo Biosciences Shares Climb on Promising Preclinical Osteoarthritis Pain Data - MSN
Artelo Biosciences Plans to Offer 920K Shares of Common Stock - AInvest
Artelo Biosciences completes reverse stock split and reports preliminary Q2 financials - Investing.com Nigeria
D. Boral Capital Upgrades Artelo Biosciences (NASDAQ:ARTL) to Buy - Defense World
D Boral Capital Upgrades Artelo Biosciences (NASDAQ:ARTL) to Strong-Buy - Defense World
Artelo Biosciences presents positive data for arthritis pain drug By Investing.com - Investing.com South Africa
Artelo Biosciences stock soars after positive preclinical pain data By Investing.com - Investing.com Nigeria
Artelo Biosciences stock soars after positive preclinical pain data - Investing.com
Artelo Biosciences Announces Positive Preclinical Efficacy Data for Art26.12 in Osteoarthritis Pain At the 35Th Annual International Cannabinoid Research Society Symposium - MarketScreener
Artelo Biosciences announces preclinical efficacy results of ART26.12 - TipRanks
Artelo Biosciences Soars 30.5% on Promising Depression Drug Data - AInvest
Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium - The Manila Times
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):